No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Female
Study type
Observational
Participants needed
40 (estimated)
Sponsor
Icahn School of Medicine at Mount Sinai · Other
Who this trial is looking for
This trial is looking for women who have gestational diabetes and are 18 or older. Participants will use a continuous glucose monitor during their pregnancy and up to 14 days after giving birth to help understand blood sugar levels after pregnancy.
Are You a Good Fit for This Trial?
Must be takingDexcom G7
You may be able to join if
I have been diagnosed with gestational diabetes during my current pregnancy.
I am 18 years old or older.
I have been prescribed Dexcom G7.
You may not be able to join if
I had diabetes before my pregnancy.
I have a skin allergy that makes it hard to use a glucose monitor.
I am taking chronic oral steroids.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose mon…
Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of gestational diabetes during current pregnancy
* age 18 or older
* prescribed Dexcom G7
Exclusion Criteria:
* Pregestational diabetes
* known skin adhesive allergy which inhibits ongoing use of CGM
* chronic oral steroid use.
Inclusion Criteria:
* Diagnosis of gestational diabetes during current pregnancy
* age 18 or older
* prescribed Dexcom G7
Exclusion Criteria:
* Pregestational diabetes
* known skin adhesive allergy which inhibits ongoing use of CGM
* chronic oral steroid use.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.